Methica CC

Almost one million women per year are falsely diagnosed for having cervical cancer, leading to severe psychological distress for the woman and an annual financial burden of €360 million per year for the European society. Implementation of the CC Diagnostics’ methylation assay will decrease false positives with 33%, will prevent emotional stressful periods for thousands of women and will save up more than €120 million of annual healthcare cost for the European society.